Juliane Marie Center, Rigshospitalet
Copenhagen
0 studies enrolling now · 7 studies all time
What they study most
Cystic Fibrosis
Studies at this site
- A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
- A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
- Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
- A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
- A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy — Stopped early
- A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
- A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed